Press Release
6 March 2025

Epoch Biodesign Raises $18.3 Million in Series A Funding

Professionals

The London and Cambridge Technology team advised Epoch Biodesign on its oversubscribed $18.3 million Series A funding.

The funding round was led by climate-focused fund Extantia Capital, with participation from Day One Ventures, Happiness Capital, Kibo Invest and Lowercarbon Capital. The round also included a strategic investment by Spanish fast fashion giant Inditex, owner of clothing brand Zara, through Mundi Ventures.

Founded in 2019, Epoch Biodesign is a U.K. startup, originating from founder Jacob Nathan’s high school science project on using enzymes to break down plastic waste. It is now a 30+ strong multidisciplinary team of chemists, biologists, and software engineers. The startup will use the new funding to scale up production of its plastic-eating enzymes. This will include transferring the biorecycling process from the labs where the team has been developing the enzymes to their first production facility this year.

The Goodwin team was led by Adam Thatcher and Duy Le.

For more details, please see here.